Kathleen Stafford
Plus aucun poste en cours
Profil
Kathleen Stafford has been Vice President-Human Resources of Onyx Pharmaceuticals, Inc. since October 2006 and a Consultant since January 2006.
Prior to joining Onyx, she was a Financial Consultant of IntraBiotics, Dynavax, Chiron and ViroLogic.
Ms. Stafford was Chief Financial Officer of AXYS Pharmaceuticals and CV Therapeutics and Treasurer of Amgen.
She received an undergraduate degree from Santa Clara University and an MBA from Virginia Polytechnic Institute.
Anciens postes connus de Kathleen Stafford
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Treasurer | - |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Directeur Financier/CFO | - |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Directeur Financier/CFO | - |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Responsable des Ressources Humaines | - |
Formation de Kathleen Stafford
| Santa Clara University | Undergraduate Degree |
| Virginia Polytechnic Institute & State University | Masters Business Admin |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |